Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI boosts brain scan accuracy in massive new trial

NCT ID NCT07471984

Diagnosis Sponsor: Yaou Liu Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an AI tool can help radiologists read brain CT and MRI scans more accurately and quickly. Researchers will compare how well doctors, AI alone, and doctors using AI together can spot abnormalities, urgent findings, and classify diseases. The goal is to reduce missed diagnoses and speed up care for conditions like strokes and brain tumors.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
AI diagnostic tool for brain CT/MRI scans
What this could lead to
If successful, this could make brain scan diagnosis faster and more accurate, helping doctors catch serious conditions like strokes or tumors earlier.
What could go wrong
This is a large validation study, but AI may not perform as well in real-world settings or with diverse patient groups. The results depend on how well doctors and AI work together.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 50,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Dec 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All patient exams are suspected of harboring brain tumors or the other neurological diseases, with or without neurological symptoms, and without a history of prior brain surgery or inpatient/outpatient medical records. Patients underwent brain CT and MRI, and were primarily examined at Beijing Tiantan hospital, between 2012-2026.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * For MRI: patients suspected of harboring ischemic, hemorrhagic, brain tumors, degenerative brain disease, or traumatic brain injury at initiating or other institution, who subsequently underwent brain MRI; * For CT: patients with or without neurological symptoms, suspected of harboring ischemic, hemorrhagic, space-occupying, degenerative brain disease, or traumatic brain injury, who subsequently underwent brain CT. Exclusion Criteria: Exclusion Criteria: * Patients who opted-out or did not give permission to reuse clinical data. * Patients with a history of prior brain surgery. * Patients whose brain CT or MRI exhibit severe artifacts (e.g. heavy warping due to air, metal artifacts, heavy motion artifacts), thereby impeding the usage of the data.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ai (artificial intelligence) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

central nervous system disorder nervous system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Ai (artificial intelligence) Central nervous system disease Classification CT Diagnose disease MRI

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Beijing Tiantan Hospital

    Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.